New insights into the ambivalent role of YAP/TAZ in human cancers
J Luo, L Deng, H Zou, Y Guo, T Tong, M Huang… - Journal of Experimental …, 2023 - Springer
Hippo signaling was first identified in Drosophila as a key controller of organ size by
regulating cell proliferation and anti-apoptosis. Subsequent studies have shown that this …
regulating cell proliferation and anti-apoptosis. Subsequent studies have shown that this …
Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics
N Li, YH Liu, J Wu, QG Liu, JB Niu, Y Zhang… - European Journal of …, 2024 - Elsevier
As a highly conserved signaling network across different species, the Hippo pathway is
involved in various biological processes. Dysregulation of the Hippo pathway could lead to a …
involved in various biological processes. Dysregulation of the Hippo pathway could lead to a …
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer
V Canu, S Vaccarella, A Sacconi, C Pulito… - Cell Death & …, 2024 - nature.com
Triple negative breast cancer (TNBC) is an aggressive disease which currently has no
effective therapeutic targets and prominent biomarkers. The Sperm Associated antigen 5 …
effective therapeutic targets and prominent biomarkers. The Sperm Associated antigen 5 …
Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression
Abstract Background Bronchial premalignant lesions (PMLs) are composed primarily of cells
resembling basal epithelial cells of the airways, which through poorly understood …
resembling basal epithelial cells of the airways, which through poorly understood …
[HTML][HTML] YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy …
Y Ning, H Zheng, Y Yang, H Zang, W Wang… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
YAP1 is a well-known core effector of the Hippo pathway in tumors, but its potential role in
osimertinib resistance remained unexplored. Our study provides evidence that YAP1 acts as …
osimertinib resistance remained unexplored. Our study provides evidence that YAP1 acts as …
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
L Lv, X Zhou - MedComm, 2023 - Wiley Online Library
As highly conserved among diverse species, Hippo signaling pathway regulates various
biological processes, including development, cell proliferation, stem cell function, tissue …
biological processes, including development, cell proliferation, stem cell function, tissue …
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma
L Wei, X Ma, Y Hou, T Zhao, R Sun, C Qiu, Y Liu… - Cell Death …, 2023 - nature.com
Progestin resistance is a problem for patients with endometrial carcinoma (EC) who require
conservative treatment with progestin, and its underlying mechanisms remain unclear. YAP …
conservative treatment with progestin, and its underlying mechanisms remain unclear. YAP …
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicity
F Lo Sardo, C Turco, B Messina, A Sacconi… - Cell Death …, 2024 - nature.com
The tumor suppressor PTEN (phosphatase and tensin homolog deleted in chromosome 10)
is genetically deleted or downregulated in many cancer types. Loss of PTEN protein …
is genetically deleted or downregulated in many cancer types. Loss of PTEN protein …
USP7 upregulated by TGF-β1 promotes ferroptosis via inhibiting LATS1-YAP axis in sepsis-induced acute lung injury
H Lv, J Yu, X Qian, J Shu, Q Qian, L Shen, D Shi, Z Tao… - Iscience, 2024 - cell.com
Our work aimed to investigate the interactive roles of transforming growth factor β1 (TGF-β1),
ubiquitin-specific-processing protease 7 (USP7), and Yes-associated protein (YAP) in …
ubiquitin-specific-processing protease 7 (USP7), and Yes-associated protein (YAP) in …
A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming
L Wang, Z Zhu, Q Liang, Y Tao, G **, Y Zhong… - Journal of Translational …, 2022 - Springer
Background Liver cancer is the fifth leading cause of cancer death worldwide, but early
diagnosis and treatment of liver cancer remains a clinical challenge. How to screen and …
diagnosis and treatment of liver cancer remains a clinical challenge. How to screen and …